On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...

Monkeypox, caused by the monkeypox virus—a close cousin of smallpox—has spread rapidly worldwide. From 2022 to 2025, more ...

Vaccines have saved more than 154 million lives worldwide over the past 50 years. World Immunization Week is a timely ...

For decades, scientists have searched for a way to outsmart Lyme disease, a stealthy infection that affects nearly half a ...

GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...

Transgene Provides Business and Financial Update for Q1 2025  TG4050: Updated randomized Phase I data to be presented in Rapid Oral Presentation at ASCO 2025Dr. Simone Steiner appointed Chief ...

GEO-MVA: A U.S.-Developed Vaccine Candidate at the Forefront of Biosecurity ...

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

French President Emmanuel Macron has promised more support to fight chikungunya on La Réunion, after a baby died from the ...

Dengue’s rise in 2024, influenced by climate change and shifting serotypes, underscores the need for effective vaccines to ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations 22.04.2025 / 15:07 CET/CEST The issuer is solely ...